Back to Journals » Diabetes, Metabolic Syndrome and Obesity » Volume 17 » DR10627, a Novel Dual Glucagon‑like Peptide‑1 and Gastric Inhibitory Polypeptide Receptor Agonist for the Treatment of Obesity and Type 2 Diabetes Mellitus
Please verify you are not a robot.